Image-guided high intensity focused ultrasound to treat breast cancerStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Magtrace/Sentimag MT599 (MIB263)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Signatera molecular residual disease assay (MT741)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years TS ID 12116Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC